We’ve built and tested a full-body device that helps ICU patients avoid Post Intensive Care Syndrome (PICS) by applying vibration to activate their muscles. The device has four entry points, two at the shoulders and two at the feet. Not only does the system apply vibrations at both ends of the skeletal system, it also compresses the body and tightens the joints so the vibrations travel all the way through the body.
Read More
Using only exhaled breath, this non-invasive, point-of-care device can identify and track over 20 lung diseases including ARDS and COVID.
Read More
The DEVD will provide caregivers from the field hospital to the ICU the ability to automatically quantify, regulate, and monitor ICP and cerebrospinal fluid (CSF) drainage. The DEVD has the potential to move an industry away from the old rope and pulley system into the modern era. Ready for wireless and analytic integration, the DEVD can also be used to stream data that can be utilized in predictive modeling for advanced TBI diagnosis and treatment.
Read More
This is a hand-held device that sends blood test results of traumatic brain injury (TBI) patients directly to a smartphone while utilizing a series of blood-based biomarkers that can be used to monitor individual patient response to TBI treatment regardless of their state. This point-of-care platform is suited for performing repeated measurements at a fraction of current hospital costs.
Read More
This innovative, handheld POC biomarker immunosensor system is a battery-operated, highly portable, pipette-shaped biomarker analysis microsystem that is wirelessly connected to a smartphone for data transmission and analysis. Because current critical care practice is insufficient to monitor the dynamic nature of sepsis, this device stands ready to improve outcomes and save lives.
Read More
The Redox Point-of-Care platform is the first to allow measurement of redox in whole blood and other fluids in the clinical setting, rapidly, in real-time - and it does it at bedside, where it is needed most to affect change. It contains sensor technology that utilizes nanoporous gold electrodes integrated into a microfluidic device to directly measure oxidation reduction (redox) in whole blood at 250 microliter sample amounts without the risk of contamination or biofouling.
Read More